ERBB2 and cancer: In 2007, the group conducted by Vasquez-Martin showed that due to the bidirectional crosstalk between the FASN and the human epidermal growth factor receptor-2 (HER2), cancer cells undergo apoptosis as the endogenous FA lipogenic pathway is inhibited 68.